Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome. [PDF]
Development of adverse outcome pathways (AOPs) for uterine adenocarcinoma can provide a practical tool to implement the EFSA‐ECHA Guidance (2018) for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No ...
EFSA Panel on Plant Protection Products and their Residues (PPR) +26 more
europepmc +4 more sources
An integrative systems biology strategy to support the development of adverse outcome pathways (AOPs): a case study on radiation-induced microcephaly. [PDF]
Adverse Outcome Pathways (AOPs) are useful tools for assessing the potential risks associated with exposure to various stressors, including chemicals and environmental contaminants.
Jaylet T +3 more
europepmc +4 more sources
Micro- and Nano-Plastics Activation of Oxidative and Inflammatory Adverse Outcome Pathways
Microplastics (MPs) and nanoplastics (NPs) have attracted considerable attention in the recent years as potential threats to the ecosystem and public health.
Dusan Palic
exaly +4 more sources
Adverse Outcome Pathways: A Concise Introduction for Toxicologists [PDF]
Adverse outcome pathways (AOPs) are designed to provide a clear-cut mechanistic representation of critical toxicological effects that propagate over different layers of biological organization from the initial interaction of a chemical with a molecular target to an adverse outcome at the individual or population level.
Mathieu Vinken +2 more
exaly +6 more sources
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways. [PDF]
Alteration in gut microbiota has been associated with COVID-19. However, the underlying mechanisms remain poorly understood. Here, we outlined three potential interconnected mechanistic pathways leading to gut dysbiosis as an adverse outcome following ...
Clerbaux LA +6 more
europepmc +4 more sources
Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study. [PDF]
The evolving landscape of chemical risk assessment is increasingly focused on developing tiered, mechanistically driven approaches that avoid the use of animal experiments.
Ortega-Vallbona R +6 more
europepmc +3 more sources
Natural language processing in toxicology: Delineating adverse outcome pathways and guiding the application of new approach methodologies. [PDF]
Highlights • Natural language processing can support adverse outcome pathways building.• Natural language processing can support new approach methodologies development.
Corradi MPF +7 more
europepmc +4 more sources
Exploring genetic influences on adverse outcome pathways using heuristic simulation and graph data science. [PDF]
Adverse outcome pathways provide a powerful tool for understanding the biological signaling cascades that lead to disease outcomes following toxicity.
Romano JD +4 more
europepmc +2 more sources
Semantic characterization of adverse outcome pathways. [PDF]
This study was undertaken to systematically assess the utilities and performance of ontology-based semantic analysis in adverse outcome pathway (AOP) research. With an increasing number of AOPs developed by scientific domain experts to organize toxicity information and facilitate chemical risk assessment, there is a pressing need for objective ...
Wang RL.
europepmc +4 more sources
Integration of Adverse Outcome Pathways, Causal Networks and 'Omics to Support Chemical Hazard Assessment. [PDF]
Several approaches have been used in an attempt to simplify and codify the events that lead to adverse effects of chemicals including systems biology, ‘omics, in vitro assays and frameworks such as the Adverse Outcome Pathway (AOP).
Perkins EJ, Woolard EA, Garcia-Reyero N.
europepmc +2 more sources

